CA 15.3 Test

What Does the CA 15.3 Test Measure?

This test measures CA 15-3, a tumour-associated marker in the blood. Serial measurements can help with:

• Cancer Monitoring: Supports assessment of tumour activity during follow-up.
• Recurrence Detection: Rising trends may suggest recurrence before symptoms appear (requires clinical correlation).
• Treatment Response: Decreasing values over time often indicate response to therapy.
• Non-cancer Causes: Mild elevations can occur in benign conditions (e.g., liver disease, endometriosis, autoimmune disorders).

CA 15.3 Test: Who Needs It and Why It’s Done

What Symptoms May Call for a CA 15.3 Test?

Your doctor may recommend this test if you have:

• A known history of breast cancer and require monitoring
• Symptoms that could suggest recurrence (e.g., persistent bone pain, fatigue, unexplained weight loss)
• Symptoms suggestive of metastasis (e.g., new lumps, persistent pain, unexplained swelling)
• Ongoing systemic therapy where marker trends may help assess response

Who Should Get a CA 15.3 Test?

This test is commonly used for:

• Patients already diagnosed with breast cancer
• Individuals being monitored after surgery, chemotherapy, radiation, or targeted therapy
• Patients with suspected metastatic or recurrent disease (as part of a broader evaluation)

Why is a CA 15.3 Test Done?

The test is used to monitor disease course in breast cancer. A rising trend may indicate progression, recurrence, or metastasis, whereas a falling trend can suggest response to treatment. Single values are less informative than trends over time.

Importance of a CA 15.3 Test

CA 15-3 is a useful tool for longitudinal monitoring in breast cancer management. It can support clinical decision-making, particularly when interpreted alongside imaging, clinical examination, and other laboratory findings. It should not be used alone to confirm or exclude cancer.

CA 15.3 Test Booking & Reports – Metropolis Healthcare

How to Book the CA 15.3 Test and Get Your Reports?

1. Simple Online Booking
   Book via the Metropolis Healthcare website or app, select “CA 15.3 Test,” and choose home collection or a lab visit.
2. Safe Sample Collection
   A trained technician collects the blood sample using sterile technique.
3. Sample Tracking Updates
   Track sample progress through the Metropolis portal/app.
4. Accurate Laboratory Testing
   Testing is typically performed using Electrochemiluminescence Immunoassay (ECLIA) in NABL & CAP accredited laboratories.
5. Quick & Easy Reports
   Reports are usually available within 8 hours via email/WhatsApp and through the Metropolis app.

Is Home Sample Collection for CA 15.3 Test Available Near You?

Yes. Home blood sample collection is generally available, subject to local service coverage. A 3 ml blood sample is typically collected in a gel vacutainer.

How Long Does It Take to Get a CA 15.3 Test Report?

Reports are generally available within 8 hours once the sample reaches the laboratory.
Note: Reporting time and cost may vary based on your location.

Where Can I See or Get CA 15.3 Test Results?

You can access your reports via the Metropolis Healthcare website/app, or receive them by email or WhatsApp. Printed reports may be collected from the nearest Metropolis lab, if required.

Interpreting CA 15.3 Test Results

Understanding Abnormal CA 15.3 Test Results

Note: Serial measurements (trends over time) are often more clinically informative than a single CA 15-3 value.

How Should You Prepare for a CA 15.3 Test?

• No fasting is required; you can eat and drink normally.
• Inform your doctor about ongoing treatments (chemotherapy, targeted therapy, immunotherapy), as trends should be interpreted in context.
• Stay well hydrated before the blood draw.
• Follow any clinician-specific guidance related to timing of testing during treatment cycles.

How Is a CA 15.3 Test Done? (Step-by-Step Procedure)

1. Preparation: A tourniquet is applied to the upper arm.
2. Cleaning: The puncture site is disinfected.
3. Sample Collection: Approximately 3 ml of blood is drawn into a gel vacutainer.
4. Processing: The sample is analysed using ECLIA to quantify CA 15-3.
5. Reporting: Results are issued with reference ranges and interpretive guidance as applicable.

Conditions That May Affect CA 15.3 Test Accuracy

• Chronic liver disease (e.g.,hepatitis, cirrhosis)
• Autoimmune disorders (e.g.,lupus)
• Benign breast conditions or inflammation
• Pregnancy or hormonal fluctuations
• Inter-laboratory method differences (reference ranges and assay platforms may vary)

Diseases That a CA 15.3 Test Can Help Detect or Monitor

• Breast cancer progression, recurrence, or metastatic disease (monitoring use)
• Response to breast cancer treatment (trend monitoring)
• Other malignancies where CA 15-3 may be elevated (supportive, non-specific): ovarian, colon, lung, pancreatic cancers
• Non-malignant conditions that can elevate tumour markers (supportive context): liver disease, autoimmune disorders

CA 15.3 Test Price in Different Cities

The cost of a CA 15.3 Test may vary depending on your location. Here's a table showing the approximate price range for the CA 15.3 Test at Metropolis Healthcare in major Indian cities:

The CA 15.3 Test cost may vary depending on the city and the specific tests included in the panel. However, Metropolis Healthcare offers competitive CA 15.3 Test prices across major cities in India.

References

1. Duffy M.J. (2006). Serum tumor markers in breast cancer: Are they of clinical value? Clinical Chemistry, 52(3), 345–351. PMID: 16467392
2. Molina R., et al. (2010). Tumor markers in breast cancer: Present and future. Clinical Biochemistry, 43(7–8), 657–665. PMID: 20096784
3. Sturgeon C.M., et al. (2008). NACB Laboratory Medicine Practice Guidelines for use of tumor markers. Clinical Chemistry, 54(12), e11–e79. PMID: 19042984